Novavax is trading 5.1% down today at $8.86 amid a broader pullback in biotech and risk assets.
- Biotech ETFs are off more than 2% as investors continue recent profit-taking in the sector.
- Major indices like the Nasdaq are under pressure from geopolitical tensions and a shift toward risk-off sentiment.
- There are no fresh company-specific headlines or analyst calls today, suggesting the stock is primarily following sector and macro trends.